This Senior Director role manages the evidence generation for the MEG Cell Therapy portfolio, including Medical Affairs Sponsored studies, Clinical Research Collaborations, and investigator-sponsored studies.
Base: $229,380 - $277,956; Bonus/Equity: Additional incentive cash and stock opportunities may be available; Benefits: Health Coverage, Wellbeing Support, Financial Well-being and Protection, Work-life benefits
Must-have
Nice-to-have
Not specified